PMID- 18669226
OWN - NLM
STAT- MEDLINE
DCOM- 20080909
LR  - 20181201
IS  - 0350-199X (Linking)
VI  - 62
IP  - 2
DP  - 2008
TI  - Statistical evaluation of olanzapine efficacy in catamnesticly investigated 
      patients.
PG  - 85-7
AB  - The aims of this research are: a) To compare GAF (Global Assessment of 
      Functioning) score after the olanzapine treatment with the GAF score recorded 
      after the treatment conducted by typical antipsychotics; b) To compare CGI 
      (Global Clinical Impression) score after the treatment with CGI subsequent to 
      treatment by typical antipsychotics; c) To compare number of hospitalizations of 
      patients during the treatment with olanzapine with the number of hospitalizations 
      during previous treatment; and 4. To monitor and record the possible weight gain 
      of patients who were taking olanzapine. The research was conducted in the period 
      from 2004 to 2007 in the Department of Psychiatry of the University Clinical 
      Center in Sarajevo. Research subjects were patients with diagnosed schizophrenia 
      who did not have expected response to the treatment with conventional 
      antipsychotics, or who experienced serious adverse effects in the course of this 
      treatment. Daily dosage of olanzapine was adjusted to the clinical condition of 
      the patient and it varied from 5 to 20 mg a day. Clinical assessment is done once 
      a month with CGI scale and GAF scale. During follow-up the possible weight gain 
      was also followed. Statistically significant difference was found (p<0.001).
FAU - Skrbo, Armin
AU  - Skrbo A
AD  - Faculty of pharmacy, University of Sarajevo.
FAU - Djedjibegovic, Jasmina
AU  - Djedjibegovic J
FAU - Jovanovic-Gmaz, Mirjana
AU  - Jovanovic-Gmaz M
FAU - Kapetanovic, Diana
AU  - Kapetanovic D
FAU - Sahovic, Dzenana
AU  - Sahovic D
FAU - Todorovic, Ljubica
AU  - Todorovic L
LA  - eng
PT  - Journal Article
PL  - Bosnia and Herzegovina
TA  - Med Arh
JT  - Medicinski arhiv
JID - 0400722
RN  - 0 (Antipsychotic Agents)
RN  - 12794-10-4 (Benzodiazepines)
RN  - N7U69T4SZR (Olanzapine)
SB  - IM
MH  - Antipsychotic Agents/adverse effects/*therapeutic use
MH  - Benzodiazepines/adverse effects/*therapeutic use
MH  - Female
MH  - Hospitalization
MH  - Humans
MH  - Male
MH  - Olanzapine
MH  - Schizophrenia/*drug therapy
EDAT- 2008/08/02 09:00
MHDA- 2008/09/10 09:00
CRDT- 2008/08/02 09:00
PHST- 2008/08/02 09:00 [pubmed]
PHST- 2008/09/10 09:00 [medline]
PHST- 2008/08/02 09:00 [entrez]
PST - ppublish
SO  - Med Arh. 2008;62(2):85-7.